Pathway is a distributor of healthcare ingredients across Australia and New Zealand, supplying to businesses in the complementary medicine, food and beverage, pharmaceutical, cosmetics and veterinary sectors
Clasado Biosciences, a developer of prebiotic ingredients and products for the human gut microbiome, has announced a partnership with specialty healthcare ingredient distributor, Pathway International.
The partnership will see the prebiotic manufacturer's galactooligosaccharide (GOS) ingredient, Bimuno, available to brands and formulators in Australia and New Zealand for the first time, with Pathway appointed as sole distributor in the region.
Pathway is a distributor of healthcare ingredients across Australia and New Zealand, supplying to businesses in the complementary medicine, food and beverage, pharmaceutical, cosmetics and veterinary sectors.
Before the ingredient becomes commercially available, the companies will collaborate on registration with the Therapeutic Goods Association (TGA), a legislative requirement for ingredients used in complementary medicines in Australia. Once approved, the ingredient will be available to brands and formulators for supplements, functional food and beverages.
The prebiotic's safety and efficacy is reportedly supported by over 100 scientific publications, including more than 20 clinical trials. It nourishes bifidobacteria, the company says, a beneficial bacteria associated with key areas of health, including digestive health, immunity, cognitive and mental health.
Per Rehné, CEO at Clasado, commented: “We’re delighted to announce our new partnership with Pathway, one of the most established names in ingredient distribution. Globally, prebiotic products are seeing a significant upward trajectory as consumers continue getting to grips with better gut health. The prebiotic market is expected to see a compound annual growth rate of 10.5%, according to Grand View Research and the regions of Australia and New Zealand are certainly no exception.
“Our beneficial gut bacteria not only support digestion, but they are also connected with areas such as immune health, cognition and mental health, with potential application in areas such as sleep health and athletic health. There is huge commercial opportunity on the table for brands, and Bimuno makes it simple to instantly uplift recipes and formulations.”
Wayne Coote, MD at Pathway, said: “Clasado’s extensively studied GOS prebiotic, Bimuno, fits perfectly within our business model and our portfolio of best-in-class ingredients. Pathway has a long history in the probiotic space and as a leading prebiotic, Bimuno makes a very natural extension of our science backed ingredients portfolio, designed to meet the growing consumer demand for gut health. We are delighted to be Clasado’s distribution partner in ANZ and look forward to establishing a new market for its Bimuno GOS in various formats.”